In a first-of-its-kind clinical trial, U.S. researchers found that people with agitation and dementia in late life who took a special medical formulation of two active ingredients found in marijuana—THC and CBD—had significantly less agitation than people who received a placebo.

How are disease-relevant molecules distributed within tissue? What changes occur even before they become visible under the microscope? Questions such as these are crucial for early diagnosis and targeted treatment in many diseases. Researchers at the Leibniz-Institut für Analytische Wissenschaften—ISAS have, for the first time, succeeded in combining two complementary analytical methods to create a high-resolution molecular map of tissue. Their map makes different biomolecules simultaneously visible and reveals their spatial distribution.

General practitioners (GPs) who smoke are less likely to advise their patients to quit, new research from Federation University has found, revealing how doctors’ own smoking behaviors can influence patient care.

The odds of human papillomavirus (HPV)-related cancers are higher among people with HIV (PWH) and solid-organ transplant recipients (SOTRs), according to a study published in JAMA Network Open.

Uterine fibroids and endometriosis are two of the most common gynecologic diseases, affecting 15% to 80% of women of childbearing age. Existing treatments—hormonal drugs and selective estrogen receptor modulators—have side effects and cannot reliably prevent recurrence. This is why less harmful non-hormonal therapies are urgently needed.